Parameters influencing the stealthiness of colloidal drug delivery systems

Puisieux, 1994, Polymeric micro and nanoparticles as drug carriers, 749 Stolnik, 1995, Long-circulating microparticulate drug carriers, Adv Drug Deliv Rev, 16, 195, 10.1016/0169-409X(95)00025-3 Allen, 1995, Pharmacokinetics of long-circulating liposomes, Adv Drug Del Rev, 16, 267, 10.1016/0169-409X(95)00029-7 Lobenberg, 1996, Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy, AIDS Res Hum Retroviruses, 12, 1709, 10.1089/aid.1996.12.1709 Gaspar, 1992, Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production, Pharm Res, 9, 782, 10.1023/A:1015807706530 Rihova, 2002, Immunomodulating activities of soluble synthetic polymer-bound drugs, Adv Drug Deliv Rev, 54, 653, 10.1016/S0169-409X(02)00043-1 Moghimi, 2001, Capture of stealth nanoparticles by the body's defences, Crit Rev Ther Drug Carrier Syst, 18, 527, 10.1615/CritRevTherDrugCarrierSyst.v18.i6.30 Adams, 1984, The cell biology of macrophage activation, Annu Rev Immunol, 2, 283, 10.1146/annurev.iy.02.040184.001435 Demoy, 1999, In vitro evaluation of nanoparticles spleen capture, Life Sci, 64, 1329, 10.1016/S0024-3205(99)00068-5 Lu, 2005, Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier, Int J Pharm, 295, 247, 10.1016/j.ijpharm.2005.01.043 Moghimi, 1999, Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography, Adv Drug Deliv Rev, 37, 295, 10.1016/S0169-409X(98)00099-4 Chen, 1997, A film tension theory of phagocytosis, J Colloid Interface Sci, 190, 118, 10.1006/jcis.1997.4865 Alberts, 2002, Internal organization of the cell−>13. Intracellular vesicular traffic Panyam, 2003, Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells, Pharm Res, 20, 212, 10.1023/A:1022219003551 Tabata, 1990, Phagocytosis of polymer microspheres by macrophages, Adv Polym Sci, 94, 107, 10.1007/BFb0043062 Mosqueira, 2001, Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules, Biomaterials, 22, 2967, 10.1016/S0142-9612(01)00043-6 Bocca, 1998, Phagocytic uptake of fluorescent stealth and no-stealth solid lipid nanoparticles, Int J Pharm, 175, 185, 10.1016/S0378-5173(98)00282-8 Thiele, 2001, Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?, J Control Release, 76, 59, 10.1016/S0168-3659(01)00412-6 Gbadamosi, 2002, PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance, FEBS Lett, 532, 338, 10.1016/S0014-5793(02)03710-9 Kaim, 2002, MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats, Radiology, 225, 808, 10.1148/radiol.2253011485 Rolland, 1987, Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles, J Immunol Methods, 96, 185, 10.1016/0022-1759(87)90313-9 Zambaux, 2000, Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig, Biomaterials, 21, 975, 10.1016/S0142-9612(99)00233-1 Duval-Araujo, 1999, 99mTC sulphur colloid phagocytosis by the mononuclear phagocytic system (MPS) of rats with portal hypertension, Minerva Chir, 54, 403 Lacasse, 1998, Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis, Pharm Res, 15, 312, 10.1023/A:1011935222652 Mosqueira, 1999, Interactions between a macrophage cell line (J774A1) and surface-modified poly (d,l-lactide) nanocapsules bearing poly(ethylene glycol), J Drug Target, 7, 65, 10.3109/10611869909085493 Papisov, 1998, Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions, Adv Drug Deliv Rev, 32, 119, 10.1016/S0169-409X(97)00135-X Patel, 1998, Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system—the concept of tissue specificity, Adv Drug Deliv Rev, 32, 45, 10.1016/S0169-409X(97)00131-2 Kiwada, 1998, Identification of proteins mediating clearance of liposomes using a liver perfusion system, Adv Drug Deliv Rev, 32, 61, 10.1016/S0169-409X(97)00132-4 Kamps, 1998, Receptor versus non-receptor mediated clearance of liposomes, Adv Drug Deliv Rev, 32, 81, 10.1016/S0169-409X(97)00133-6 Sparrow, 1989, A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein, J Biol Chem, 264, 2599, 10.1016/S0021-9258(19)81655-1 Patel, 1992, Serum opsonins and liposomes: their interaction and opsonophagocytosis, Crit Rev Ther Drug Carrier Syst, 9, 39 Liu, 1996, Serum independent liposome uptake by mouse liver, Biochim Biophys Acta, 1278, 5, 10.1016/0005-2736(95)00196-4 Liu, 1995, Liposome clearance from blood: different animal species have different mechanisms, Biochim Biophys Acta, 1240, 277, 10.1016/0005-2736(95)00184-0 van Furth, 1985, Morphological, cytochemical, functional, and proliferative characteristics of four murine macrophage-like cell lines, Cell Immunol, 90, 339, 10.1016/0008-8749(85)90199-6 Harashima, 1996, Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism, Pharm Res, 13, 1049, 10.1023/A:1016058724452 Kinoshita, 1991, Biology of complement: the overture, Immunol Today, 12, 291, 10.1016/0167-5699(91)90001-A Osmand, 1977, Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins), Proc Natl Acad Sci USA, 74, 739, 10.1073/pnas.74.2.739 Bristow, 1986, Evidence for the binding of human serum amyloid P component to Clq and Fab gamma, Mol Immunol, 23, 1045, 10.1016/0161-5890(86)90003-9 Volanakis, 1974, Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q, J Immunol, 113, 9, 10.4049/jimmunol.113.1.9 Siegel, 1975, Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-l-lysine polymers and other polycations, J Exp Med, 142, 709, 10.1084/jem.142.3.709 Sahu, 2001, Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, Immunol Rev, 180, 35, 10.1034/j.1600-065X.2001.1800103.x Passirani, 1998, Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sci, 62, 775, 10.1016/S0024-3205(97)01175-2 Szebeni, 1998, Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study, J Natl Cancer Inst, 90, 300, 10.1093/jnci/90.4.300 Kazatchkine, 1986 Kabat, 1961 Gref, 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Adv Drug Deliv Rev, 16, 215, 10.1016/0169-409X(95)00026-4 Dunn, 1994, Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution, Pharm Res, 11, 1016, 10.1023/A:1018939521589 Peracchia, 1997, Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles, Life Sci, 61, 749, 10.1016/S0024-3205(97)00539-0 Vittaz, 1996, Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators, Biomaterials, 17, 1575, 10.1016/0142-9612(95)00322-3 Cruz, 1997, Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production, Pharm Res, 14, 73, 10.1023/A:1012059501947 Muller, 2000, Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art, Eur J Pharm Biopharm, 50, 161, 10.1016/S0939-6411(00)00087-4 Chellat, 2005, Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles, Biomaterials, 26, 961, 10.1016/j.biomaterials.2004.04.006 Heurtault B, Saulnier P, Benoit JP, Proust JE, Pech B, Richard J. Nanocapsules lipidiques, procédé de préparation et utilisation comme médicament. French Patent No. 00 02688,2000. Heurtault, 2002, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharm Res, 19, 875, 10.1023/A:1016121319668 Lamprecht, 2004, Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment, Int J Pharm, 278, 407, 10.1016/j.ijpharm.2004.03.018 Bradley, 1998, Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids, Arch Biochem Biophys, 357, 185, 10.1006/abbi.1998.0798 Volanakis, 1981, Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement, J Immunol, 126, 1820, 10.4049/jimmunol.126.5.1820 Thiel, 1992, Mannan-binding protein, a complement activating animal lectin, Immunopharmacology, 24, 91, 10.1016/0162-3109(92)90015-5 Kuhlman, 1989, The human mannose-binding protein functions as an opsonin, J Exp Med, 169, 1733, 10.1084/jem.169.5.1733 Illum, 1986, The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages, Int J Pharma, 29, 53, 10.1016/0378-5173(86)90199-7 Cullis, 1998, Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo, Adv Drug Deliv Rev, 32, 3, 10.1016/S0169-409X(97)00128-2 Mold, 1989, Effect of membrane phospholipids on activation of the alternative complement pathway, J Immunol, 143, 1663, 10.4049/jimmunol.143.5.1663 Derksen, 1987, Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro, Exp Cell Res, 168, 105, 10.1016/0014-4827(87)90420-4 Allen, 1991, Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size, Biochim Biophys Acta, 1061, 56, 10.1016/0005-2736(91)90268-D Nilsson, 1993, Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface, Mol Immunol, 30, 211, 10.1016/0161-5890(93)90050-L Harashima, 1996, Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats, Pharm Res, 13, 1704, 10.1023/A:1016401025747 Chonn, 1991, The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J Immunol, 146, 4234, 10.4049/jimmunol.146.12.4234 Torchilin, 1994, Why do polyethylene glycol-coated liposomes circulate so long? (molecular mechanism of liposome steric protection with polyethylene glycol: role of polymer chain flexibility), J Liposome Res, 4, 725, 10.3109/08982109409037068 Montdargent, 1993, Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces, Biomaterials, 14, 203, 10.1016/0142-9612(93)90024-V Chonn, 1995, Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of “non-self” particles, J Biol Chem, 270, 25845, 10.1074/jbc.270.43.25845 Horkko, 1997, The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins), Proc Natl Acad Sci USA, 94, 10356, 10.1073/pnas.94.19.10356 Moghimi, 2000, Poloxamers and poloxamines in nanoparticle engineering and experimental medicine, Trends Biotechnol, 18, 412, 10.1016/S0167-7799(00)01485-2 Alving, 1991, Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity, Crit Rev Immunol, 10, 441 Carreno, 1988, Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum, Biomaterials, 9, 514, 10.1016/0142-9612(88)90047-6 Maillet, 1991, Specific antibodies enhance alternative complement pathway activation by cuprophane, Nephrol Dial Transplant, 6, 193, 10.1093/ndt/6.3.193 Videm, 1994, Human complement activation by polygeline and dextran 70, Scand J Immunol, 39, 314, 10.1111/j.1365-3083.1994.tb03377.x Passirani, 2005, Complement activation by injectable colloidal drug carriers, 187 Harashima, 1995, Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling, J Drug Target, 3, 253, 10.3109/10611869509015954 Roerdink, 1983, Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement, Biochim Biophys Acta, 734, 33, 10.1016/0005-2736(83)90071-8 Mosesson, 1980, The structure and biologic activities of plasma fibronectin, Blood, 56, 145, 10.1182/blood.V56.2.145.145 Hautanen, 1983, Affinity of myeloma IgG proteins for fibronectin, Clin Exp Immunol, 53, 233 Rossi, 1983, Binding of fibronectin to phospholipid vesicles, J Biol Chem, 258, 3327, 10.1016/S0021-9258(18)32864-3 Cardarelli, 1990, High-affinity binding of fibronectin to cultured Kupffer cells, J Leukoc Biol, 48, 426, 10.1002/jlb.48.5.426 Czop, 1986, Phagocytosis of particulate activators of the alternative complement pathway: effects of fibronectin, Adv Immunol, 38, 361, 10.1016/S0065-2776(08)60011-5 Bradley, 1998, The complement system in liposome clearance: can complement deposition be inhibited?, Adv Drug Deliv Rev, 32, 19, 10.1016/S0169-409X(97)00129-4 Moghimi, 2003, Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Prog Lipid Res, 42, 463, 10.1016/S0163-7827(03)00033-X Yu, 1997, Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids, J Clin Invest, 99, 315, 10.1172/JCI119160 Devitt, 1998, Human CD14 mediates recognition and phagocytosis of apoptotic cells, Nature, 392, 505, 10.1038/33169 Shibuya-Fujiwara, 2001, Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors, Life Sci, 70, 291, 10.1016/S0024-3205(01)01392-3 Harmon, 1993, Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids, J Membr Biol, 133, 43, 10.1007/BF00231876 Rigotti, 1995, The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids, J Biol Chem, 270, 16221, 10.1074/jbc.270.27.16221 Serra, 1992, Enhanced IgG- and complement-independent phagocytosis of sulfatide-enriched human erythrocytes by human monocytes, FEBS Lett, 311, 67, 10.1016/0014-5793(92)81369-W Huang, 2002, Uptake of FITC-chitosan nanoparticles by A549 cells, Pharm Res, 19, 1488, 10.1023/A:1020404615898 Lee, 1993, Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes, Biochemistry, 32, 889, 10.1021/bi00054a021 Nussbaum, 1992, Fusion of influenza virus particles with liposomes: requirement for cholesterol and virus receptors to allow fusion with and lysis of neutral but not of negatively charged liposomes, J Gen Virol, 73, 2831, 10.1099/0022-1317-73-11-2831 Juliano, 1975, Biochem, Biophys Res Commun, 63, 651, 10.1016/S0006-291X(75)80433-5 Senior, 1987, Fate and behavior of liposomes in vivo: a review of controlling factors, Crit Rev Ther Drug Carrier Syst, 3, 123 Harashima, 1994, Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes, Pharm Res, 11, 402, 10.1023/A:1018965121222 Devine, 1994, Liposome-complement interactions in rat serum: implications for liposome survival studies, Biochim Biophys Acta, 1191, 43, 10.1016/0005-2736(94)90231-3 Rudt, 1993, In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution, Eur J Pharma Sci, 1, 31, 10.1016/0928-0987(93)90015-3 Li, 1994, Surface properties of pluronic-coated polymeric colloids, Langmuir, 10, 4475, 10.1021/la00024a016 Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 2006, in press. Smith, 1982, Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement, J Biol Chem, 257, 9879, 10.1016/S0021-9258(18)33952-8 Schwendener, 1984, The effects of charge and size on the interaction of unilamellar liposomes with macrophages, Biochim Biophys Acta, 772, 93, 10.1016/0005-2736(84)90521-2 Pratten, 1986, Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro, Biochim Biophys Acta, 881, 307, 10.1016/0304-4165(86)90020-6 Harashima, 1993, Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency, J Pharmacokinet Biopharm, 21, 299, 10.1007/BF01059781 Vincent, 1993, Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia, DNA Cell Biol, 12, 415, 10.1089/dna.1993.12.415 Spanjer, 1986, Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition, Biochim Biophys Acta, 863, 224, 10.1016/0005-2736(86)90262-2 Gabizon, 1992, The role of surface charge and hydrophilic groups on liposome clearance in vivo, Biochim Biophys Acta, 1103, 94, 10.1016/0005-2736(92)90061-P Tabata, 1988, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials, 9, 356, 10.1016/0142-9612(88)90033-6 Luck, 1998, Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics, J Biomed Mater Res, 39, 478, 10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6 Claesson, 1995, Protein interactions at solid interface, Adv Colloid Interface Sci, 57, 161, 10.1016/0001-8686(95)00241-H Jeon, 1991, Protein-surface interactions in the presence of polyethylene oxide I. Simplified theory, J Colloid Interface Sci, 142, 149, 10.1016/0021-9797(91)90043-8 Jeon, 1991, Protein–surface interactions in the presence of polyethylene oxide. II: effect of protein size, J Colloid Interface Sci, 142, 159, 10.1016/0021-9797(91)90044-9 Nagaoka, 1985, 331 Nagaoka, 1984, Interaction between blood components and hydrogels with poly(oxyethylene) chains, 361 Israelachvili, 1985 Vermette, 2003, Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: relation to physico-chemical properties and mechanisms, Colloids Surf B: Biointerfaces, 28, 153, 10.1016/S0927-7765(02)00160-1 Ahl, 1997, Enhancement of the in vivo circulation lifetime of l-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization, Biochim Biophys Acta, 1329, 370, 10.1016/S0005-2736(97)00129-6 Chonn, 1992, Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes, J Biol Chem, 267, 18759, 10.1016/S0021-9258(19)37026-7 Black, 1976, Interaction of liposomes with blood plasma proteins, Biochem Soc Trans, 4, 253, 10.1042/bst0040253a Molnar, 1977, The role of an alpha2-macroglobulin of rat serum in the phagocytosis of colloidal particles, Biochim Biophys Acta, 493, 37, 10.1016/0005-2795(77)90258-6 Juliano, 1980, The binding of human plasma proteins to cholesterol containing liposomes, 49 Gref, 2000, ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids Surf B Biointerfaces, 18, 301, 10.1016/S0927-7765(99)00156-3 Moghimi, 1993, Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim Biophys Acta—Mol Cell Res, 1179, 157, 10.1016/0167-4889(93)90137-E Dijkstra, 1985, Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles, Biochim Biophys Acta, 813, 287, 10.1016/0005-2736(85)90244-5 Hsu, 1982, Interactions of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages, Biochim Biophys Acta, 720, 411, 10.1016/0167-4889(82)90120-3 Roser, 1998, Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats, Eur J Pharm Biopharm, 46, 255, 10.1016/S0939-6411(98)00038-1 Wilhelm, 2003, Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating, Biomaterials, 24, 1001, 10.1016/S0142-9612(02)00440-4 Lee, 1992, Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density, Biochim Biophys Acta—Biomembran, 1103, 185, 10.1016/0005-2736(92)90086-2 Vetvicka, 1987, Polymer microbeads in immunology, Biomaterials, 8, 341, 10.1016/0142-9612(87)90003-2 Allen, 1994, The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system, AdV Drug Del Rev, 13, 285, 10.1016/0169-409X(94)90016-7 Macritchie, 1972, The adsorption of proteins at the solid/liquid interface, J Colloid Interface Sci, 38, 484, 10.1016/0021-9797(72)90264-0 Golander, 1992, Properties of immobilized PEG films and interaction with proteins, experiments and modelling, 221 Allen, 1981, A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles, Biochim Biophys Acta, 640, 385, 10.1016/0005-2736(81)90464-8 van Oss, 1978, Phagocytosis as a surface phenomenon, Annu Rev Microbiol, 32, 19, 10.1146/annurev.mi.32.100178.000315 Van Oss, 1975 Moghimi, 2002, Liposome recognition by resident and newly recruited murine liver macrophages, J Liposome Res, 12, 67, 10.1081/LPR-120004778 Cevc, 1999, Lipid vesicles and membrane fusion, Adv Drug Deliv Rev, 38, 207, 10.1016/S0169-409X(99)00030-7 Burgess, 1991, Poly(ethylene glycol)-induced lipid mixing but not fusion between synthetic phosphatidylcholine large unilamellar vesicles, Biochemistry, 30, 4193, 10.1021/bi00231a013 Coleman, 1982, Blood-materials interactions: the minimum interfacial free energy and the optimum polar/apolar ratio hypotheses, J Biomed Mater Res, 16, 381, 10.1002/jbm.820160407 Lee, 1990, Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings, Biomaterials, 11, 455, 10.1016/0142-9612(90)90058-X Lemarchand, 2004, Polysaccharide-decorated nanoparticles, Eur J Pharma Biopharm, 58, 327, 10.1016/j.ejpb.2004.02.016 Calvo, 1996, Improved ocular bioavailability of indomethacin by novel ocular drug carriers, J Pharm Pharmacol, 48, 1147, 10.1111/j.2042-7158.1996.tb03911.x Jordan, 1999, Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro, J Magn Magn Mater, 194, 185, 10.1016/S0304-8853(98)00558-7 Bazile, 1995, PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system, J Pharm Sci, 84, 493, 10.1002/jps.2600840420 Torchilin, 1995, Which polymers can make nanoparticulate drug carriers long-circulating?, Adv Drug Deliv Rev, 16, 141, 10.1016/0169-409X(95)00022-Y Maruyama, 1992, Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol), Biochim Biophys Acta, 1128, 44, 10.1016/0005-2760(92)90255-T Torchilin, 1998, Polymer-coated long-circulating microparticulate pharmaceuticals, J Microencapsul, 15, 1, 10.3109/02652049809006831 Illum, 1987, Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages, Biomaterials, 8, 113, 10.1016/0142-9612(87)90099-8 Osterberg, 1995, Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG, J Biomed Mater Res, 29, 741, 10.1002/jbm.820290610 Heurtault, 2003, Interfacial stability of lipid nanocapsules, Colloids Surf B: Biointerfaces, 30, 225, 10.1016/S0927-7765(03)00096-1 Antonsen, 1992, Water structure of PEG solutions by diffrential calorimetry measurements, 15 Szleifer, 1997, Polymers and proteins: interactions at interfaces, Current Opin Solid State Mater Sci, 2, 337, 10.1016/S1359-0286(97)80125-8 Pavey, 1999, SPR analysis of the total reduction of protein adsorption to surfaces coated with mixtures of long- and short-chain polyethylene oxide block copolymers, Biomaterials, 20, 885, 10.1016/S0142-9612(98)00245-2 Moghimi, 2003, Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908, FEBS Lett, 547, 177, 10.1016/S0014-5793(03)00707-5 Huang, 2004, Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation, Pharm Res, 21, 344, 10.1023/B:PHAM.0000016249.52831.a5 Watrous-Peltier, 1992, Direct suppression of phagocytosis by amphipathic polymeric surfactants, Pharm Res, 9, 1177, 10.1023/A:1015855906472 Amiji, 1997, Synthesis of anionic poly(ethylene glycol) derivative for chitosan surface modification in blood-contacting applications, Carbohydrate Polym, 32, 193, 10.1016/S0144-8617(97)00006-4 Zambaux, 1999, MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties, J Biomed Mater Res, 44, 109, 10.1002/(SICI)1097-4636(199901)44:1<109::AID-JBM12>3.0.CO;2-C Gombotz, 1991, Protein adsorption to poly(ethylene oxide) surfaces, J Biomed Mater Res, 25, 1547, 10.1002/jbm.820251211 Benecky, 1990, Human plasma fibronectin structure probed by steady-state fluorescence polarization: evidence for a rigid oblate structure, Biochemistry, 29, 3082, 10.1021/bi00464a027 Lim K, Herron JN. Molecular simulation of protein PEG interaction. In: Harris JME, editor. Poly(ethylene glycol) chemistry: biotechnical and biomedical applications. New York: Plenum Press; 1992. p. 29–55. Kingshott, 2002, Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins, Biomaterials, 23, 2043, 10.1016/S0142-9612(01)00334-9 Stolnik, 2001, The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers, Biochim Biophys Acta, 1514, 261, 10.1016/S0005-2736(01)00376-5 Bergstrom, 1994, Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection, J Biomater Sci Polym Ed, 6, 123, 10.1163/156856294X00257 Kenworthy, 1995, Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol), Biophys J, 68, 1903, 10.1016/S0006-3495(95)80368-1 Yang, 1999, Protein interactions with poly(ethylene glycol) self-assembled monolayers on glass substrates: diffusion and adsorption, Langmuir, 15, 8405, 10.1021/la990260y Razatos, 2000, Force measurements between bacteria and poly(ethylene glycol)-coated surfaces, Langmuir, 16, 9155, 10.1021/la000818y Papisov, 1995, Amplification of steric effects in cooperative systems, 442 Johnstone, 2001, Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages, Biochim Biophys Acta, 1513, 25, 10.1016/S0005-2736(01)00292-9 Torchilin, 1994, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim Biophys Acta, 1195, 11, 10.1016/0005-2736(94)90003-5 Labarre, 2002, Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation, Biomaterials, 23, 2319, 10.1016/S0142-9612(01)00366-0 Lemarchand, 2006, Influence of polysaccharide coating on the interactions of nanoparticles with biological systems, Biomaterials, 10.1016/j.biomaterials.2005.04.041 Woodle, 1992, Sterically stabilized liposomes, Biochim Biophys Acta, 1113, 171, 10.1016/0304-4157(92)90038-C Chaffee, 1992, IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency, J Clin Invest, 89, 1643, 10.1172/JCI115761 Wilkinson, 1979, Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers, Infect Immun, 23, 502, 10.1128/IAI.23.2.502-508.1979 Kurata, 1989, Viscosity-molecular weight relationships and unperturbed dimensions of linear chain molecules, VII/1 Thiele, 2003, Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells, Biomaterials, 24, 1409, 10.1016/S0142-9612(02)00525-2 Allemann, 1997, Kinetics of blood component adsorption on poly(d,l-lactic acid) nanoparticles: evidence of complement C3 component involvement, J Biomed Mater Res, 37, 229, 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9 Kreuter, 2001, Nanoparticulate systems for brain delivery of drugs, Adv Drug Deliv Rev, 47, 65, 10.1016/S0169-409X(00)00122-8